Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674732013 | Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3674734014 | Mesalamine 250 mg gastro-resistant oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3674735010 | Mesalazine 250 mg gastro-resistant oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
66625101000001119 | Mesalazine 250mg gastro-resistant tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Mesalazine 250mg e/c tablet - product | Is a | False | Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet | Inferred relationship | Existential restriction modifier | |
Salofalk 250mg gastro-resistant tablets (Dr Falk Pharma UK Ltd) | Is a | True | Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg gastro-resistant tablets 100 tablet | Is pack of | False | Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg gastro-resistant tablets 100 tablet | Has VMP | True | Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets